1. Home
  2. RVP vs NRSN Comparison

RVP vs NRSN Comparison

Compare RVP & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

N/A

Current Price

$0.70

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.79

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVP
NRSN
Founded
1994
2017
Country
United States
Israel
Employees
N/A
15
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
24.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
RVP
NRSN
Price
$0.70
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
19.0K
187.1K
Earning Date
05-14-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$38,266,211.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.78
N/A
52 Week Low
$0.62
$0.63
52 Week High
$1.14
$2.60

Technical Indicators

Market Signals
Indicator
RVP
NRSN
Relative Strength Index (RSI) 51.89 48.55
Support Level $0.69 $0.66
Resistance Level $0.73 $1.30
Average True Range (ATR) 0.04 0.07
MACD -0.00 0.01
Stochastic Oscillator 47.73 72.13

Price Performance

Historical Comparison
RVP
NRSN

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: